Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118082334 | 11808233 | 4 | F | 20111214 | 20160902 | 20151207 | 20160909 | EXP | US-DSJP-DSU-2015-137283 | DAIICHI | 0.00 | Y | 0.00000 | 20160909 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118082334 | 11808233 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 20 MG, UNK | U | 21286 | 20 | MG | TABLET | |||||||
| 118082334 | 11808233 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, UNK | U | 21286 | 40 | MG | TABLET | |||||||
| 118082334 | 11808233 | 3 | C | FOLIC ACID. | FOLIC ACID | 1 | 1 MG, BID | 0 | 1 | MG | BID | ||||||||
| 118082334 | 11808233 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 118082334 | 11808233 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 118082334 | 11808233 | 6 | C | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | 200 MG, BID | 0 | 200 | MG | BID | ||||||||
| 118082334 | 11808233 | 7 | C | KOMBIGLYZE XR | METFORMIN HYDROCHLORIDESAXAGLIPTIN HYDROCHLORIDE | 1 | 2.5 MG, TWO EACH EVENING | 0 | 2.5 | MG | |||||||||
| 118082334 | 11808233 | 8 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | UNK | 0 | |||||||||||
| 118082334 | 11808233 | 9 | C | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 118082334 | 11808233 | 10 | C | GLYMEPIRIDE | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118082334 | 11808233 | 1 | Hypertension |
| 118082334 | 11808233 | 3 | Product used for unknown indication |
| 118082334 | 11808233 | 4 | Product used for unknown indication |
| 118082334 | 11808233 | 5 | Product used for unknown indication |
| 118082334 | 11808233 | 6 | Product used for unknown indication |
| 118082334 | 11808233 | 7 | Product used for unknown indication |
| 118082334 | 11808233 | 8 | Product used for unknown indication |
| 118082334 | 11808233 | 9 | Product used for unknown indication |
| 118082334 | 11808233 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118082334 | 11808233 | HO |
| 118082334 | 11808233 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118082334 | 11808233 | Chronic kidney disease | |
| 118082334 | 11808233 | Constipation | |
| 118082334 | 11808233 | Diverticulitis | |
| 118082334 | 11808233 | Haemorrhoids | |
| 118082334 | 11808233 | Intercapillary glomerulosclerosis | |
| 118082334 | 11808233 | Malabsorption | |
| 118082334 | 11808233 | Nephrotic syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118082334 | 11808233 | 1 | 2010 | 2011 | 0 | |
| 118082334 | 11808233 | 3 | 20121222 | 0 | ||
| 118082334 | 11808233 | 4 | 20111223 | 0 | ||
| 118082334 | 11808233 | 6 | 20121222 | 0 |